AC Immune (ACIU) Free Cash Flow (2015 - 2025)

AC Immune (ACIU) has reported Free Cash Flow for 11 consecutive years, with -$20.8 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Free Cash Flow fell 402.45% year-over-year to -$20.8 million; the TTM figure through Mar 2026 stood at -$63.2 million (down 225.27% YoY), while the FY2025 annual figure was -$84.5 million, down 211.47% from the prior year.
• Free Cash Flow improved to -$20.8 million in Q4 2025 per ACIU's latest filing, from -$23.3 million in the prior quarter.
• Across five years, Free Cash Flow topped out at $80.8 million in Q2 2024 and bottomed at -$24.5 million in Q1 2022.
• Historically, Free Cash Flow has averaged -$11.6 million across 5 years, with a median of -$18.1 million in 2023.
• Annual changes were most pronounced in 2024 — Free Cash Flow soared 617.89% — and 2025, when it slumped 1548.68%.
• AC Immune's Free Cash Flow stood at -$24.3 million in 2021, then increased by 15.12% to -$20.6 million in 2022, then climbed by 11.32% to -$18.3 million in 2023, then surged by 137.64% to $6.9 million in 2024, then plunged by 402.45% to -$20.8 million in 2025.
• Business Quant data shows ACIU's Free Cash Flow at -$20.8 million in Q4 2025, -$23.3 million in Q3 2025, and -$19.1 million in Q2 2025.